• Fangchinoline, TFEB, and Anti-H1N1 Lysosomal Defense

  2026-08-18

  The reference study identifies fangchinoline as a host-directed anti-influenza compound that restores TFEB-associated lysosomal biogenesis while disrupting endolysosomal trafficking required for H1N1 entry. Its combined use of Connectivity Map screening, transcriptomic analysis, lysosomal assays, time-resolved infection experiments, and in vivo validation provides a framework for studying lysosome-targeted antiviral mechanisms.

• iPSC Cardiomyocytes for Chemical Risk Characterization

  2026-08-18

  The reference study shows that combining concentration-response transcriptomics with functional testing in human iPSC-derived cardiomyocytes can improve chemical hazard prioritization and mechanistic interpretation. Across 464 chemicals, the integrated framework linked cardiomyocyte phenotypes, gene-expression changes, points of departure, and exposure information without relying on electrophysiology alone.

• AG-120 (Ivosidenib) Workflow for IDH1 Research

  2026-08-17

  Build a rigorous mutant-IDH1 workflow around AG-120 (Ivosidenib), linking 2-hydroxyglutarate reduction to proliferation, metabolism, and myeloid differentiation. The strategy also uses CD44 status and NADPH-linked readouts to distinguish target engagement from resistance or assay failure.

• Merimepodib (VX-497): IMPDH Inhibitor Guide

  2026-08-17

  Merimepodib, also known as VX-497, is a selective, noncompetitive, orally bioavailable IMPDH inhibitor. By limiting guanine nucleotide biosynthesis, it supports research on lymphocyte proliferation, immunosuppression, oncology, and host-directed antiviral mechanisms.

• NF-κB–Apaf1 Axis in Septic Acute Kidney Injury

  2026-08-16

  A 2026 study identifies an NF-κB/Apaf1/caspase-9 pathway that suppresses autophagy and promotes tubular apoptosis and inflammation during septic acute kidney injury. Genetic and pharmacological experiments position Apaf1 and caspase-9 as mechanistic links between inflammatory signaling, defective autophagy, and renal tubular damage, providing a framework for testing pathway-directed interventions.

• AG-221 (Enasidenib) in IDH2 AML Research

  2026-08-15

  AG-221 (Enasidenib) combines genotype-focused IDH2 inhibition with measurable 2-hydroxyglutarate reduction, making it useful for mechanism-led acute myeloid leukemia research. This guide shows how to connect metabolite, viability, differentiation, and CD44-metabolism readouts in a practical workflow while avoiding common assay failures.

• (-)-Blebbistatin for Mechanobiology Workflows

  2026-08-14

  (-)-Blebbistatin is a reversible, cell-permeable non-muscle myosin II inhibitor for separating actomyosin force generation from F-actin remodeling. This guide translates intermittent-stress mechanomemory findings into practical workflows for YAP translocation, cytoskeletal dynamics research, migration assays, and contractility studies.

• Phosphatase Inhibitor Cocktail 3: Protocol

  2026-08-14

  Phosphatase Inhibitor Cocktail 3 (100X in DMSO) helps limit dephosphorylation during cell and tissue lysate preparation, supporting phosphoprotein analysis by Western blotting, immunoprecipitation, imaging, and kinase assays. It is intended for addition to lysates rather than unvalidated use in live cells, and its broad activity profile should be confirmed for each target phosphatase and assay.

• Amikacin Sulfate in Reliable Cell Assays

  2026-08-13

  Learn how Amikacin Sulfate, SKU C8696, can help control bacterial confounding in viability, proliferation, and cytotoxicity workflows. This scenario-based guide explains dose interpretation, host-cell compatibility, storage, data analysis, and practical product selection for intracellular infection research.

• CD44 Metabolic Rewiring in IDH-Mutant Leukemia

  2026-08-13

  The reference study identifies CD44-mediated metabolic rewiring as a dependency that enables IDH-mutant leukemia cells to generate NADPH and sustain production of the oncometabolite R-2HG. Its isogenic CRISPR-based design connects CD44 activity to pentose phosphate pathway activation, glycolytic suppression, and enhanced sensitivity to combined IDH and CD44 targeting.

• Tofacitinib Citrate: JAK3 Research Guide

  2026-08-12

  Tofacitinib citrate, also called CP-690550 citrate, is a nanomolar-range JAK3-directed research inhibitor with weaker activity against JAK1 and JAK2. It supports immune regulation research and JAK-STAT pathway experiments, but endothelial findings show that concentration and inflammatory context strongly affect interpretation.

• Perospirone Inhibits Coronary Kv1.5 Channels

  2026-08-12

  A 2025 Journal of Applied Toxicology study identifies vascular voltage-gated potassium channels as a previously unrecognized off-target site of perospirone action. Using freshly isolated rabbit coronary arterial smooth muscle cells, the authors show concentration-dependent, use-independent Kv inhibition with pharmacological evidence implicating Kv1.5, expanding the antipsychotic drug mechanism discussion toward cardiovascular electrophysiology.

• Fumagillin Workflows for Angiogenesis Research

  2026-08-11

  Fumagillin provides a mechanistically defined route to study MetAP-2-dependent endothelial responses, while the reference study adds a useful antiparasitic assay framework. This guide connects stock preparation, dose-response design, tumor-model applications, and troubleshooting without treating cross-domain findings as interchangeable.

• FerroOrange for Live-Cell Fe²⁺ Detection

  2026-08-11

  FerroOrange enables selective live-cell Fe²⁺ measurements across microscopy, flow cytometry, and plate-reader workflows. Its value is greatest when intracellular iron detection is paired with ferroptosis, microglial activation, and neuronal injury assays rather than used as a standalone death marker.

• Pentoxifylline and Preterm Monocyte Hyperinflammation

  2026-08-10

  The reference study showed that Pentoxifylline suppresses LPS-driven inflammatory activation in monocytes from preterm infants, with effects involving reduced TLR4 expression and signaling. Its age-stratified design links cytokine, surface-marker, phagocytic, and molecular readouts while also highlighting limitations relevant to neonatal sepsis translation.

15645 records 1/1043 page Next 12345 下5页 Last page